Delaware
(State
or Other Jurisdiction
of
Incorporation)
|
000-30929
(Commission
File Number)
|
13-4087132
(IRS
Employer Identification No.)
|
£ |
Written
communications pursuant to Rule 425 under the Securities
Act.
|
£ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 14d-2b under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act.
|
(d)
|
Exhibits | |
The
following exhibit is filed as a part of this
report:
|
||
Exhibit
|
||
Number
|
Description | |
99.1
|
Press Release dated October 4, 2006. |
Keryx Biopharmaceuticals, Inc. | ||
(Registrant) | ||
|
|
|
Date: October 4, 2006 | By: | /s/ Ronald C. Renaud, Jr. |
Ronald C. Renaud, Jr. |
||
Senior Vice President, Chief Financial Officer, Secretary and Treasurer |
Exhibit
|
||
Number
|
Description | |
99.1
|
Press Release dated October 4, 2006. |